A scoring system for histopathologic and immunohistochemical evaluations of uterine leiomyosarcomas

Oncology Reports

Volumn 22, Issue 4, 2009, Pages 725-731

  Yoshida, Chika ^a   Ichimura, Tomoyuki ^a   Kawamura, Naoki ^b   Nakano, Akemi ^a   Kasai, Mari ^a   Sumi, Toshiyuki ^a   Ishiko, Osamu ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b OSAKA CITY GENERAL HOSPITAL   (Japan)

Author keywords

D34; Ki 67; Leiomyosarcoma; Necrosis; Needle biopsy

Indexed keywords

CD34 ANTIGEN; EOSIN; HEMATOXYLIN; KI 67 ANTIGEN;

ADULT; ANTIGEN EXPRESSION; ARTICLE; CANCER STAGING; CELL PROLIFERATION; COAGULATIVE TUMOR CELL NECROSIS; CONTROLLED STUDY; CYTOLOGIC ATYPIA; CYTOLOGY; DIAGNOSTIC ACCURACY; FEMALE; HIGH RISK PATIENT; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MITOSIS; NECROSIS; NEEDLE BIOPSY; PREDICTION; PREOPERATIVE PERIOD; PRIORITY JOURNAL; SCORING SYSTEM; TRANSCERVICAL NEEDLE BIOPSY; UTERUS MYOMA;

ANTIGENS, CD34; BIOPSY, NEEDLE; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; LEIOMYOMA; LEIOMYOSARCOMA; MIDDLE AGED; MITOTIC INDEX; ROC CURVE; SENSITIVITY AND SPECIFICITY; UTERINE NEOPLASMS;

EID: 70350355054     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or_00000493     Document Type: Article

References (18)

1. Vollenhoven BJ, Lawrence AS and Healy DL: Uterine fibroids: a clinical review. Br J Obstet Gynaecol 97: 285-298, 1990.
2. Adamson GD: Treatment of uterine fibroids: current findings with gonadotropin-releasing hormone agonists. Am J Obstet Gynecol 166: 746-751, 1992.
3. McLucas B, Adler L and Perrella R: Uterine fibroid embolization: nonsurgical treatment for symptomatic fibroids. J Am Coll Surg 192: 95-105, 2001.
4. Kawamura N, Iwanaga N, Hada S, et al: Transient shrinkage of a uterine leiomyosarcoma treated with GnRH agonist for a presumed uterine leiomyoma: comparison of magnetic resonance imaging finding before and during GnRH agonist treatment. Oncol Rep 8: 1255-1257, 2001.
5. Kawamura N, Ito F, Ichimura T, et al: Transient rapid growth of uterine leiomyoma in a postmenopausal woman. Oncol Rep 6: 1289-1292, 1999.
6. Schwartz LB, Diamond MP and Schwartz PE: Leiomyosarcomas: clinical presentation. Am J Obstet Gynecol 168: 180-183, 1993.
7. Kawamura N, Shibata S, Ito F, Ichimura T, Umesaki N and Ogita S: Practical method for transcervical needle biopsy of uterine leiomyomas to avoid unnecessary surgery. J Gynecol Tech 2: 201-206, 1996.
8. Kawamura N, Ichimura T, Ito F, et al: Transcervical needle biopsy for the differential diagnosis between uterine sarcoma and leiomyoma. Cancer 94: 1713-1720, 2002.
9. Kawamura N, Ichimura T, Takahashi K, Tujimura A, Ishiko O and Ogita S: Transcervical needle biopsy of uterine myoma-like tumor using an automatic biopsy gun. Fertil Steril 77: 1060-1064, 2002.
10. Bell SW, Kempson RL and Hendrickson MR: Problematic uterine smooth muscle neoplasms. A clinicopathologic study of 213 cases. Am J Surg Pathol 18: 535-558, 1994.
11. Parker WH, Fu YS and Berek JS: Uterine sarcoma in patients operated on for presumed leiomyoma and rapidly growing leiomyoma. Obstet Gynecol 83: 414-418, 1994.
12. Buttram VC Jr and Reiter RC: Uterine leiomyomata: etiology, symptomatology and management. Fertil Steril 36: 433-445, 1981.
13. Cattoretti G, Becker MH, Key G, et al: Monoclonal antibodies against recombinant parts of the Ki-67 antigen (MIB1 and MIB3) detect proliferating cells in microwave-processed formalin-fixed paraffin sections. J Pathol 168: 357-363, 1992.
14. Layfield LJ, Liu K, Dodge R and Barsky SH: Uterine smooth muscle tumors: utility of classification by proliferation, ploidy, and prognostic markers versus traditional histopathology. Arch Pathol Lab Med 124: 221-227, 2000.
15. Mayerhofer K, Lozanov P, Bodner K, Bodner-Adler B, Kimberger O and Czerwenka K: Ki-67 expression in patients with uterine leiomyomas, uterine smooth muscle tumors of uncertain malignant potential (STUMP) and uterine leiomyosarcomas (LMS). Acta Obstet Gynecol Scand 83: 1085-1088, 2004.
16. Mittal K and Demopoulos RI: MIB-1 (Ki-67), p53, estrogen receptor, and progesterone receptor expression in uterine smooth muscle tumors. Hum Pathol 32: 984-987, 2001.
17. Chen L and Yang B: Immunohistochemical analysis of P16, P53 and Ki-67 expression in uterine smooth muscle tumors. Int J Gynecol Pathol 27: 326-332, 2008.
18. Cramer SF, Newcomb PM and Bonfiglio TA: Myometrial dysplasia (atypical myometrial hyperplasia). Hum Pathol 38: 652-655, 2007.